Cold Chain Distribution: Keeping Temperature-Sensitive Medicines Safe
A growing share of modern medicines must be kept cold. Vaccines, insulins, many biologics and a number of injectable treatments need to stay within tight temperature ranges, often 2 to 8 degrees Celsius, from the moment they leave the manufacturer until they are used.
Why the cold chain breaks
Temperature excursions rarely happen in the warehouse. They usually happen at handover points: loading bays, delivery vans, a busy dispensary counter or a clinic fridge that is opened too often. Each handover is a risk.
What good cold-chain practice looks like
Validated packaging that has been tested to hold temperature for the full journey time.
Data loggers or temperature indicators so the receiver can see what happened in transit.
Clear instructions on what to do if a delivery arrives outside its range.
Fridges at the receiving site that are monitored, recorded and serviced.
The cost of getting it wrong
An excursion can mean stock has to be quarantined or destroyed, and in the worst case a patient may receive a product that no longer works as intended. For clinics running high-value treatments, a single failed delivery can wipe out the margin on dozens of appointments.
Building cold-chain resilience
Work with suppliers who can show you their packaging validation and who use logistics partners experienced in medical deliveries. Acorn Pharmaceuticals is investing in dedicated logistics capacity so that temperature-sensitive orders for UK and international customers are handled with the care they need.
Talk to Acorn Pharmaceuticals: email gb@acornpharmaceuticals.co.uk or message us on WhatsApp.
Comments